Close Menu

The Wall Street Journal has an article focusing on Andrew von Eschenbach, commissioner of the US Food and Drug Administration. Critics have charged that the FDA can't manage regulations of everything it's supposed to be regulating, and now von Eschenbach responds that "the agency needs more money than the Bush administration has proposed, and it requires a revamped organization to better oversee drug safety and other issues," according to the article.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.